99 related articles for article (PubMed ID: 3014200)
1. Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity.
Nolibé D; Poupon MF
J Natl Cancer Inst; 1986 Jul; 77(1):99-103. PubMed ID: 3014200
[TBL] [Abstract][Full Text] [Related]
2. In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double-stranded polynucleotides.
Nolibe D; Aumaitre E; Thang MN
Cancer Res; 1985 Oct; 45(10):4774-8. PubMed ID: 4027965
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cloning efficiency of murine rhabdomyosarcoma cells after chlorozotocin treatment: relationship with enhanced lung metastasis.
Pauwels C; Rebischung JL; Jasmin C; Poupon MF
J Natl Cancer Inst; 1985 Apr; 74(4):817-20. PubMed ID: 3157818
[TBL] [Abstract][Full Text] [Related]
5. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
[TBL] [Abstract][Full Text] [Related]
6. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
8. Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.
Florentin I; Nolibe D; Giroud JP
Int J Exp Pathol; 1991 Feb; 72(1):83-95. PubMed ID: 1653591
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis.
Shakhar G; Abudarham N; Melamed R; Schwartz Y; Rosenne E; Ben-Eliyahu S
Ann Surg Oncol; 2007 Feb; 14(2):841-52. PubMed ID: 17091332
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
11. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
12. Renewal of natural killer cells in mice having elevated natural killer cell activity.
Nassiry L; Miller SC
Nat Immun Cell Growth Regul; 1987; 6(5):250-9. PubMed ID: 3444438
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1981 Dec; 67(6):1317-22. PubMed ID: 6947114
[TBL] [Abstract][Full Text] [Related]
14. Amplified pulmonary metastases of a rat rhabdomyosarcoma in response to nitrosourea treatment.
Poupon MF; Pauwels C; Jasmin C; Antoine E; Lascaux V; Rosa B
Cancer Treat Rep; 1984 May; 68(5):749-58. PubMed ID: 6233004
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the activity of mouse natural killer cells by urethan.
Gorelik E; Herberman RB
J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
[TBL] [Abstract][Full Text] [Related]
17. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
18. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.
Shakhar G; Ben-Eliyahu S
J Immunol; 1998 Apr; 160(7):3251-8. PubMed ID: 9531281
[TBL] [Abstract][Full Text] [Related]
19. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
Kalland T; Forsberg JG
J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
[TBL] [Abstract][Full Text] [Related]
20. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
